AI takes on radiologists in prostate cancer detection trial
NCT ID NCT07647445
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study compares an AI algorithm to radiologists in reading prostate MRI scans to detect clinically significant prostate cancer. About 500 men with suspected prostate cancer will have their MRI read by both AI and a radiologist, and results will be compared. If the AI performs just as well, it could help address the global shortage of radiologists.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI algorithm (Lucida Pi) for interpreting prostate MRI scans
- What this could lead to
- If successful, this could show that AI can reliably detect prostate cancer on MRI, helping to speed up diagnosis and reduce the workload on radiologists.
- What could go wrong
- This is an early-stage trial with 500 participants, and AI may miss some cancers or flag too many false alarms. It is not yet proven in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study aims to improve prostate cancer detection for trans community
- Could a menopause drug cool hot flashes in men with prostate cancer?
- New drug cocktail aims to shrink prostate tumors before surgery
- Triple-Drug attack before prostate surgery shows promise in early trial
- New combo therapy aims to wipe out prostate tumors before surgery
- Could two radiation doses beat five for prostate cancer?